Research collaboration with SLU

Evidensia and the Swedish University of Agricultural Sciences agree to strengthen their joint research efforts


Evidensia and the Swedish University of Agricultural Sciences (SLU) have signed a Letter of Intent with the aim of increasing the amount of jointly undertaken research. The goal is to create better conditions for clinical research and strengthen veterinary research in the Nordic countries, thus improving the welfare and well-being of humans and animals alike.

Sverre Seierstad, Research Coordinator at Evidensia, said: “Evidensia has a clear role to carry out research in areas where it is evident it could lead to concrete benefits for patient health. What is important is to give our staff the opportunity to develop their skills by researching the clinical problems we are continually encountering. 

“In addition, external validation of potential projects improves research quality and it is very important that the science takes place in close collaboration with academia. That is why we are very pleased to have signed this Letter of Intent with the University of Agricultural Sciences.” 

The specific areas of agreed collaboration are: 

  • Clinical veterinary medicine and animal care with a focus on animals in sports and household pets
  • Supplementary training at national and international level for animal health personnel

 
Torkel Ekman, Deputy Dean, Faculty of Veterinary Medicine and Animal Science at the University of Agricultural Sciences, said: “We see this as the beginning of a collaboration with the veterinary care industry. We are hoping for further, similar agreements with other industry actors and are pleased to be a part of this together with Evidensia.”

Evidensia and SLU are already working together on a number of research projects, including one on biomarkers in healthy cats as well as cats with heart disease. Another project seeks to achieve the isolation of normal bacteria and viruses in cases of kennel cough in dogs. There is also a joint research programme into serum levels in dogs with testicular cancer.